The healthy functioning of the nervous system depends on the integrity of the myelin sheath that surrounds nerve cells. The myelin sheath is a protective layer that allows electrical signals to be transmitted quickly and accurately along the nerve. When this layer is damaged, nerve transmission slows, becomes disrupted, or may stop entirely. The condition leading to this scenario is known as demyelination, and the group of diseases causing this is referred to as demyelinating diseases. Demyelination observed in areas of the central nervous system, such as the brain and spinal cord, can directly affect a person's movement, sensory function, vision, balance, and cognitive processes.
Demyelinating diseases are a group that occurs due to damage to the myelin sheath in the nervous system caused by the immune system, infections, metabolic disorders, and various environmental factors. The destruction of the myelin layer not only slows the speed of communication in the nerve cell, but can also weaken nerve fibers and affect all functions of the nervous system.
These diseases are seen in the central nervous system, but there are also types that affect the peripheral nervous system. The most well-known example affecting the central nervous system is Multiple Sclerosis (MS); Acute Disseminated Encephalomyelitis (ADEM), seen in childhood; and Neuromyelitis Optica (NMO), which affects the optic nerve, can also be included in the group of demyelinating diseases.
The appearance of demyelination foci in brain MR imaging indicates that there is damage to the myelin layer, nerve conduction is beginning to deteriorate, and neurological symptoms can be explained. Although this finding alone does not mean MS, it is important for neurological assessment. The number, distribution, and new plaque formation of the lesions provide critical information about the course of the disease.
Demyelination does not occur for a single reason. Genetic predisposition, infections, immune system disorders, and environmental factors can work together.
The immune system mistakenly targeting and attacking the myelin sheath is the most common mechanism. MS, NMO, and MOG-related demyelinating diseases can be considered autoimmune-based.
Viral infections can trigger an immune response in the nervous system, causing damage to the myelin sheath. ADEM in children usually occurs after viral infections.
Some individuals may belong to a more susceptible group due to genetic differences affecting immune responses or myelin production. Having similar diseases in family members can increase the risk.
Some metabolic disorders, like vitamin B12 deficiency, can directly cause myelin loss in nerves. If not corrected, permanent nerve damage can develop in such cases.
Certain chemicals, heavy metals, or toxic substances can cause damage to nerve tissue, leading to demyelination.
Very rarely, spinal cord injuries or some surgical situations can lead to myelin loss in nerve tissue.
The symptoms of demyelinating diseases vary depending on the affected nerve region. The location, extent, and progression rate of the damage can determine the severity of symptoms.
Muscle weakness and slowed movements
Blurred vision, double vision, visual loss attacks
Balance disorder, frequent falls, walking difficulty
Numbness, tingling, reduced sensation
Loss of coordination in hands and legs
Speech disorders (dysarthria) or difficulty swallowing
Cognitive function difficulties, attention and memory problems
Excessive fatigue and a feeling of exhaustion
Changes in bladder and bowel control
Dizziness and difficulty focusing
The diagnosis of demyelinating diseases requires a multidimensional assessment. During the diagnostic process, the patient's clinical findings, neurological examination findings, and advanced imaging methods are used together.
Reflexes, sensory functions, muscle strength, coordination, and visual nerve functions are evaluated in detail.
Brain and spinal cord MR is the most important method in visualizing demyelination foci. The number, size, location of plaques, and new lesion development provide information about the disease's course.
Samples taken via lumbar puncture are analyzed for evidence of the immune system's hyperactivity.
Blood tests can be conducted to identify demyelination causes such as infections, autoimmune diseases, and B12 deficiency.
These tests measure the conduction speed of visual, auditory, and somatosensory nerve pathways and can detect slowed nerve conduction.
Treatment varies according to the type of disease, progression rate, and severity of symptoms. Although each demyelinating disease has different management principles, the general treatment approach can be summarized as follows:
High-dose corticosteroids are used in sudden-onset neurological symptoms to control inflammation in nerve tissue.
In chronic diseases like MS, drugs that reduce the immune system's hyperactivity and slow plaque formation can be used.
Supportive therapies for controlling specific symptoms like muscle spasm, fatigue, pain, and bladder dysfunction can be applied.
Regular rehabilitation programs are important to increase muscle strength, improve walking balance, and support quality of life.
Sleep regulation, controlled exercise, stress management, and balanced nutrition can have a positive effect by supporting nervous system function.
It can vary depending on the type of disease. Some demyelinating conditions may be temporary, while it may not be possible to completely cure some chronic diseases. However, early diagnosis and correct treatment can slow progression and improve quality of life.
Yes, some types like ADEM are more commonly seen in childhood. Symptoms appearing in early stages should definitely be evaluated.
Genetic predisposition can increase disease risk but is not solely determinative. Environmental factors and immune system response also play important roles.
Stress can affect the immune system, causing flare-ups in some autoimmune diseases. While not exactly a cause, it is considered among risk-enhancing factors.